{"name":"Bond Avillion 2 Development LP","slug":"bond-avillion-2-development-lp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BDA MDI","genericName":"BDA MDI","slug":"bda-mdi","indication":"Asthma","status":"phase_3"}]}],"pipeline":[{"name":"BDA MDI","genericName":"BDA MDI","slug":"bda-mdi","phase":"phase_3","mechanism":"BDA MDI is a medication that works by delivering a specific dose of a therapeutic agent directly to the lungs.","indications":["Asthma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPWFlKZDBJWDNhV0JaMDNHdGwzNGFSbEpIbFFFUEhVRlljVVF5bXJ0dl9lUEJQLXZvN0p1YjVtbDlPTzdfZDhTRnR0ckpRT0M4VVRudDA1STExejVPNGNub2NQUF9saVZSdUFfUDYzV29hNmpkZndrOUM1eVVTNlVkOV8xMGRoUTc0SmZGVmNya1pjRWZLVEtsTkJtS1VvV1dhRkszNl9RMU1vNnFwenp5WkZhY2tkSndBSkFiRC1JQ04tbjN0OVhnTA?oc=5","date":"2025-10-01","type":"regulatory","source":"Pharmacy Times","summary":"Albuterol/Budesonide Label Updated to Include Clinically Meaningful Evidence From BATURA Study - Pharmacy Times","headline":"Albuterol/Budesonide Label Updated to Include Clinically Meaningful Evidence From BATURA Study","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}